Substance / Medication

Oxaprozin potassium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Association of health literacy with disease outcomes in inflammatory arthritis: a systematic review.
Dey Mrinalini, Budhathoki Shyam, Elwell Helen et al. · Ann Rheum Dis · 2026
PMID: 40940284Meta-Analysis
Association between weather conditions and rheumatoid arthritis: A systematic review and meta-analysis.
Hu Chao, Wu Jingyi, Luo Yuanyuan et al. · Autoimmun Rev · 2026
PMID: 41083015Meta-Analysis
Long-term persistence of biological agents in the treatment of patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
Schneeberger Emilce Edith, Felquer María Laura Acosta, Citera Gustavo et al. · Clin Rheumatol · 2026
PMID: 41160371Meta-Analysis
Obesity as a Risk Factor for Autoimmune Diseases: A Systematic Review and Meta-Analysis.
Spatocco Ilaria, Mele Giorgia, De Rosa Giusy et al. · Obesity (Silver Spring) · 2026
PMID: 41186974Meta-AnalysisFull text (PMC)
IL17 genetic variants impact the response and safety of TNFi treatment in rheumatoid arthritis patients from Bahia, Brazil.
de Sá Garcia Landeiro Lilian, Silva Dos Santos Rodrigues Pedro Augusto, de Oliveira Almirane Lima et al. · Gene · 2026
PMID: 41274389Meta-Analysis
Serum Calprotectin - What is the Scope of Clinical Application?
Cho Ha-Eun, Lee Jae Joon, Cho Sun Young · Clin Lab · 2026
PMID: 41543095Meta-Analysis
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients.
Pham Thao-Nguyen, Largajolli Anna, Sardu Maria Luisa et al. · CPT Pharmacometrics Syst Pharmacol · 2026
PMID: 41556362Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Oxaprozin potassium (substance)
SNOMED CT
427736002
UMLS CUI
C1709373

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

4
Conditions
2
Biomarkers
1
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.